Full name :
First name :
Mail :
Zip Code :
City :
Country :
Email :
Phone :
Fax :
Website :
Directory :
| Title : A Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Adding Omarigliptin to Insulin Therapy in Japanese Patients with Type 2 Diabetes and Inadequate Glycemic Control - Kadowaki_2021_Diabetes.Obes.Metab__ |
| Author(s) : Kadowaki T , Seino Y , Kaku K , Okamoto T , Kameya M , Sato A , Hirano T , Oshima N , Gantz I , O'Neill EA , Engel SS |
| Ref : Diabetes Obes Metab , : , 2021 |
| Abstract : Kadowaki_2021_Diabetes.Obes.Metab__ |
| ESTHER : Kadowaki_2021_Diabetes.Obes.Metab__ |
| PubMedSearch : Kadowaki_2021_Diabetes.Obes.Metab__ |
| PubMedID: 33512755 |
| Title : Mechanism of lipid-lowering action of the dipeptidyl peptidase-4 inhibitor, anagliptin, in low-density lipoprotein receptor-deficient mice - Yano_2017_J.Diabetes.Investig_8_155 |
| Author(s) : Yano W , Inoue N , Ito S , Itou T , Yasumura M , Yoshinaka Y , Hagita S , Goto M , Nakagawa T , Inoue K , Tanabe S , Kaku K |
| Ref : J Diabetes Investig , 8 :155 , 2017 |
| Abstract : Yano_2017_J.Diabetes.Investig_8_155 |
| ESTHER : Yano_2017_J.Diabetes.Investig_8_155 |
| PubMedSearch : Yano_2017_J.Diabetes.Investig_8_155 |
| PubMedID: 27860391 |
| Title : Safety evaluation of trelagliptin in the treatment of Japanese type 2 diabetes mellitus patients - Kaku_2017_Expert.Opin.Drug.Saf_16_1313 |
| Author(s) : Kaku K |
| Ref : Expert Opin Drug Safety , 16 :1313 , 2017 |
| Abstract : Kaku_2017_Expert.Opin.Drug.Saf_16_1313 |
| ESTHER : Kaku_2017_Expert.Opin.Drug.Saf_16_1313 |
| PubMedSearch : Kaku_2017_Expert.Opin.Drug.Saf_16_1313 |
| PubMedID: 28829213 |
| Title : First novel once-weekly DPP-4 inhibitor, trelagliptin, for the treatment of type 2 diabetes mellitus - Kaku_2015_Expert.Opin.Pharmacother_16_2539 |
| Author(s) : Kaku K |
| Ref : Expert Opin Pharmacother , 16 :2539 , 2015 |
| Abstract : Kaku_2015_Expert.Opin.Pharmacother_16_2539 |
| ESTHER : Kaku_2015_Expert.Opin.Pharmacother_16_2539 |
| PubMedSearch : Kaku_2015_Expert.Opin.Pharmacother_16_2539 |
| PubMedID: 26523434 |
| Title : SYR-472, a novel once-weekly dipeptidyl peptidase-4 (DPP-4) inhibitor, in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial - Inagaki_2014_Lancet.Diabetes.Endocrinol_2_125 |
| Author(s) : Inagaki N , Onouchi H , Sano H , Funao N , Kuroda S , Kaku K |
| Ref : Lancet Diabetes Endocrinol , 2 :125 , 2014 |
| Abstract : Inagaki_2014_Lancet.Diabetes.Endocrinol_2_125 |
| ESTHER : Inagaki_2014_Lancet.Diabetes.Endocrinol_2_125 |
| PubMedSearch : Inagaki_2014_Lancet.Diabetes.Endocrinol_2_125 |
| PubMedID: 24622716 |
| Title : A novel complex deletion-insertion mutation mediated by Alu repetitive elements leads to lipoprotein lipase deficiency - Okubo_2007_Mol.Genet.Metab_92_229 |
| Author(s) : Okubo M , Horinishi A , Saito M , Ebara T , Endo Y , Kaku K , Murase T , Eto M |
| Ref : Mol Genet Metab , 92 :229 , 2007 |
| Abstract : Okubo_2007_Mol.Genet.Metab_92_229 |
| ESTHER : Okubo_2007_Mol.Genet.Metab_92_229 |
| PubMedSearch : Okubo_2007_Mol.Genet.Metab_92_229 |
| PubMedID: 17706445 |
| Title : Effects of activin A\/erythroid differentiation factor on erythroid and megakaryocytic differentiations of mouse erythroleukemia (Friend) cells: evidence for two distinct modes of cell response - Okafuji_1995_Exp.Hematol_23_210 |
| Author(s) : Okafuji K , Kaku K , Seguchi M , Tanaka H , Azuno Y , Kaneko T |
| Ref : Experimental Hematology , 23 :210 , 1995 |
| Abstract : Okafuji_1995_Exp.Hematol_23_210 |
| ESTHER : Okafuji_1995_Exp.Hematol_23_210 |
| PubMedSearch : Okafuji_1995_Exp.Hematol_23_210 |
| PubMedID: 7875239 |